Journal of Pharmacoeconomics and Pharmaceutical Management 2015. 1(2):65-68.

Factors affecting technology commercialization in Iranian knowledge based pharmaceutical companies
Ramin Radmanesh, Abbas Kebriaeezadeh

Abstract


Background: Looking at the performance of the Iranian knowledge based pharmaceutical companies in recent years shows that, despite extensive capabilities in technological
development, many companies involved in technology commercialization have been unsuccessful. Studies show that many components have played role in success or failure
of technology commercialization in such companies. This study attempts to identify, and measure the impact of factors affecting technology commercialization in knowledge
based pharmaceutical companies, and provides recommendations and considerations for active managers in this field. Methods: In this survey, questionnaires were
distributed among 10 knowledge based pharmaceutical companies with 19 commercial products. The data were collected, and analyzed to rank the factors based on
importance. Results: Support of senior management, organizational and operational characteristics, extraction of new product concepts, forming risk-taking team and project
management, have the greatest impact on technology commercialization in these companies. Conclusions: Based on the study results, adequate attention to these elements
by the managers of knowledge based companies can lead to success in technology commercialization actions in knowledge based pharmaceutical companies.

Keywords


Commercialization, Technology commercialization, Knowledge-based Companies.

Full Text:

PDF

References


(1) Mousai MH. Designing a Model to Identify Opportunity and Their

Commercialization in Research and Development and Development

of Technology. JOTMI Research Group.1378 14(4) 15.

(2) Lux D, Rorke M. From Invention to Innovation. Produced for the U.S.

Department of Energy.1999. DOE/GO-10099-810. Retrieved August

, 2008 from http://www1.eere.energy.gov/inventions/pdfs/

fromi2i.pdf

(3) Markham K. Product champions: Crossing the valley of death.

Belliveau P, Griffin A, Somermeyer SM the PDMA Tool book for New

Product Development. 2004. 119-140.

(4) Bandarian R. From Idea to Market in RIPI; an agile Frame for NTD

Process. Journal of Technology Management and Innovation. 2007

(1).

(5) Hogan JE. New product success: Enhance your new product

development process with value gates. http://www.

strategicpricinggroup.com/pdfs/new_product_success.pdf

(Accessed 26/5/2014).

(6) Kotler P. Marketing Management: Analysis, Planning, Implementation,

and Control. 1994, Prentice Hall 8th ed. Englewood Cliffs, New Jersey.

(7) Lemmetyinen J. Commercialization of Biopharmaceuticals, Master’s

thesis submitted in partial fulfillment of the requirements for the

degree of Master of Science in Economics, Lappeenranta University

of Technology, Helsinki; 2001.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.